Abstract:Background: The shape of the mitral valve is remodeled as heart function changes, even before cardiac decompensation and obvious clinical symptoms appear. How does the early mitral valve morphology change in carriers of pathogenic gene mutation in hypertrophic cardiomyopathy(HCM)? Methods: Whole exome sequencing was performed on the probands of 258 families affected by HCM. Ninety-one families with definite pathogenic gene mutations. Sanger sequencing of families with definitive diseasecausing gene mutations was performed to verify the genotype, which was divided into the HCM group (G+/LVH+, n = 167); pathogenic gene mutationcarrying group (G+/LVH-, n = 149); and non-pathogenic gene mutationcarrying group (G-/LVH-, n = 189). Two-dimensional and three-dimensional ultrasound images were acquired from all family members, and mitral valve morphology parameters were analyzed and compared among the groups. Results: The results showed that the anteroposterior diameter and annulus height of G+/LVH+ were higher than those of G+/LVH- and G-/LVH-. The anterolateral-posteromedial diameter and sphericity index of G+/LVH+ and G+/LVH- differed significantly from those of G-/LVH-. The annulus circumference (3D), annulus area (2D), and annulus area (3D) of G+/LVH- were significantly lower than those of G+/LVH+ and G-/LVH-. The leaflets tenting volume, tenting height, commissural diameter, and annular height-to-commissural width ratio (AHCWR) (%) of G+/LVH- were significantly lower than those of G-/LVH- (1.4 ± 1.2 vs. 1.9 ± 0.9, p < 0.001) (7.7 ± 2.4 vs. 8.2 ± 2.0, p < 0.05), (2.8 ± 0.5 vs. 3.3 ± 0.3, p < 0.001), (23.1 ± 7.1 vs. 25.9 ± 6.5, p < 0.05). The angle between the mitral annulus plane and aortic valve annulus plane of G+/LVH+ was lower than that of G-/LVH- (134.4 ± 16.4 vs. 138.4 ± 13.4). Further studies revealed that mitral valve morphology parameters in the MYBPC3+/LVHgroup were significantly reduced compared with G-/LVH- group, whereas those parameters in the MYH7+/LVH- group showed no significant differences. Conclusions: Mitral valve morphological parameters show early deformation with a flatter appearance in pathogenic gene mutation carriers. They can be used as sensitive parameters to detect abnormal cardiac function in carriers of HCM, particularly in the carriers of MYBPC3 gene mutations. Funding Statement: This study was supported by grant no. 81671685 from the National Science Foundation of China and grant no. 17411954400 from the Science and Technology Committee Foundation of Shanghai. Declaration of Interests: The authors stated: None. Ethics Approval Statement: The study was approved by the Ethics Committee of Zhongshan Hospital, affiliated to Fudan University (no. 2016-16B), and all subjects gave informed consent.

Mitral valve leaflet length as an important factor to differentiate hypertrophic cardiomyopathy from other causes of left ventricular hypertrophy

Evaluation of left ventricular myocardial strain of patients with hypertrophic cardiomyopathy using cardiac magnetic resonance imaging

Mitral Geometry on the Mechanism of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy

MYH7 mutation is associated with mitral valve leaflet elongation in patients with obstructive hypertrophic cardiomyopathy

Residual mitral leaflet length independently indicates left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

Myocardial Contraction Fraction as a Simple Marker of Disease Severity in Hypertrophic Cardiomyopathy

GW27-e1170 Investigation of Mitral Leaflet Elongation in Patients with Non-obstructive and Latent-obstructive Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy With Elongated Mitral Valve Leaflets: Clinical Characteristics and Surgical Results

Echocardiographic Strain in Hypertrophic Cardiomyopathy and Hypertensive Left Ventricular Hypertrophy.

Left Ventricular Strain Patterns and Their Relationships with Cardiac Biomarkers in Hypertrophic Cardiomyopathy Patients with Preserved Left Ventricular Ejection Fraction

Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy: the Utility of Myocardial Strain Based on Cardiac MR Tissue Tracking.

Evaluation of potential links between phenotypic features and genetic variants in left ventricular outflow tract obstruction in hypertrophic cardiomyopathy using cardiovascular magnetic resonance imaging

Fluid-structure interaction simulation of pathological mitral valve dynamics in a coupled mitral valve-left ventricle model

Myocardial Mechanics Parameters That Predict Left Ventricular Outflow Tract Obstruction in Patients with Hypertrophic Cardiomyopathy: A Cardiovascular Magnetic Resonance Feature Tracking Analysis.

Differences in Clinical Features of Hypertrophic Cardiomyopathy with or Without Left Ventricular Enlargement

Pattern of Mitral Leaflet Elongation and Its Association With Functional Mitral Regurgitation in Nonischemic Dilated Cardiomyopathy

Morphological Changes in the Mitral Valve of Pathogenic Gene Mutation Carriers of Familial Hypertrophic Cardiomyopathy

Global Circumferential Strain by Cardiac Magnetic Resonance Tissue Tracking Associated With Ventricular Arrhythmias in Hypertrophic Cardiomyopathy Patients

Systolic anterior motion of the anterior mitral valve leaflet begins in subclinical hypertrophic cardiomyopathy

The role of cardiac magnetic resonance-based feature-tracking strain analysis in the differential diagnosis and prognostic assessment of patients with left ventricular hypertrophy

Assessment and Regression Analysis of Left Ventricular Mass with Cardiovascular Magnetic Resonance in Patients of Hypertrophic Cardiomyopathy